These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36574352)

  • 41. Acute Coronary Syndrome With Unprotected Left Main Coronary Artery Culprit　- An Observation From the AOI-LMCA Registry.
    Higami H; Toyofuku M; Morimoto T; Ohya M; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kadota K; Kimura T;
    Circ J; 2018 Dec; 83(1):198-208. PubMed ID: 30416191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.
    Abramson BL; Benlian P; Hanson ME; Lin J; Shah A; Tershakovec AM
    Lipids Health Dis; 2011 Aug; 10():146. PubMed ID: 21859459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of pulmonary artery capacitance with long-term outcomes in acute coronary syndrome patients with left ventricular systolic dysfunction.
    Hsieh SY; Yeh JK; Huang YC; Chen DY; Ho MY; Chen CC; Hsieh IC; Hsieh MJ
    Sci Prog; 2024; 107(4):368504241291125. PubMed ID: 39632596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
    Carvalho PEP; Gewehr DM; Nascimento BR; Melo L; Burkhardt G; Rivera A; Braga MAP; Guimarães PO; Mehran R; Windecker S; Valgimigli M; Angiolillo DJ; Bhatt DL; Sandoval Y; Chen SL; Stone GW; Lopes RD
    JAMA Cardiol; 2024 Dec; 9(12):1094-1105. PubMed ID: 39382876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
    Spirito A; Valgimigli M; Cao D; Baber U; Mehta SR; Gibson CM; Steg GP; Sharma SK; Goel R; Huber K; Kunadian V; Escaned J; Franzone A; Yaling H; Collier T; Kaul U; Kornowski R; Krucoff M; Moliterno D; Sartori S; Owen R; Zhang Z; Dangas GD; Kastrati A; Angiolillo DJ; Cohen DJ; Vranckx P; Windecker S; Pocock S; Mehran R
    Int J Cardiol; 2023 Jul; 383():24-32. PubMed ID: 37080466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
    Karakasis P; Fragakis N; Kouskouras K; Karamitsos T; Patoulias D; Rizzo M
    Clin Ther; 2024 Nov; 46(11):841-850. PubMed ID: 38991865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lipid-Lowering Therapy for Patients with Dyslipidemia].
    Yokota C
    No Shinkei Geka; 2024 Nov; 52(6):1155-1166. PubMed ID: 39622321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.
    Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM
    Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid Lowering Drugs in Acute Coronary Syndromes (ACS).
    Arnold N; Koenig W
    Curr Atheroscler Rep; 2023 Dec; 25(12):939-946. PubMed ID: 38015336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933
    [No Abstract]   [Full Text] [Related]  

  • 52. [Statins in the management of acute coronary syndrome].
    Matoba T; Egashira K
    Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.
    Claessen BE; Guedeney P; Gibson CM; Angiolillo DJ; Cao D; Lepor N; Mehran R
    J Am Heart Assoc; 2020 Dec; 9(24):e018897. PubMed ID: 33289416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia　- An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS).
    Kodera S; Morita H; Kiyosue A; Ando J; Komuro I
    Circ J; 2018 Mar; 82(4):1076-1082. PubMed ID: 29367520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology].
    Zeng YY; Liu J; Liu J; Hao YC; Yang N; Zhou MG; Hu GL; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Dec; 48(12):1039-1046. PubMed ID: 33355748
    [No Abstract]   [Full Text] [Related]  

  • 56. Addition of the Tilburg Frailty Indicator to the classic Global Registry of Acute Coronary Events risk score improves its prognostic value in elderly patients with acute coronary syndrome.
    Wontor R; Ołpińska B; Łoboz-Rudnicka M; Wyderka R; Dudek K; Łoboz-Grudzień K; Jaroch J
    Pol Arch Intern Med; 2024 Nov; 134(11):. PubMed ID: 39404816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.
    Qureshi AA; Reis JC; Qureshi N; Papasian CJ; Morrison DC; Schaefer DM
    Lipids Health Dis; 2011 Feb; 10():39. PubMed ID: 21356098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis.
    Dimmitt SB; Martin JH
    Med J Aust; 2019 Sep; 211(6):284-284.e1. PubMed ID: 31441063
    [No Abstract]   [Full Text] [Related]  

  • 59. Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis.
    Brieger DB; Weaver J; Kritharides L
    Med J Aust; 2019 Sep; 211(6):285-285.e1. PubMed ID: 31441055
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy.
    Wei Z; Wang F; Zhang L; Dai W
    Br J Hosp Med (Lond); 2024 Nov; 85(11):1-13. PubMed ID: 39618211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.